We are delighted to welcome Siobhan Southam to 7i Group as Director, Medical Affairs Services.
Siobhan joins at an exciting time for both 7i Group and the ever-evolving role of pharma/biotech medical affairs.
With a growing and diverse range of stakeholders, there is increasing demand for insights to inform medical strategies, research areas, evidence generation and prioritisation and evaluation of medical affairs activities. Advances in technology, AI and digital approaches mean that large amounts of data are generated and being able to interpret this evidence and surface the insights that add value is increasingly important. Data is no longer confined to that generated by companies; digital is transforming both the patient and physician experience.
Innovative approaches are needed to respond to this changing landscape, utilising internal and external data sources, digital channels and social media to gain understanding to maximise the impact of medical affairs activities and demonstrate added value and patient benefit. We are ideally placed to combine scientific and medical insight expertise using advanced research methodologies, tools and technology to partner with our clients to develop insights and innovative solutions to inform medical and evidence generation strategies.